[PDF][PDF] Methotrexate side effects: review article

E Gaies, N Jebabli, S Trabelsi, I Salouage… - J Drug Metab …, 2012 - researchgate.net
Methotrextae (MTX) is an antifolate first developed to treat certain types of cancer. It was used
at higher doses as a cancer therapy and since 1990 it is used at much lower doses to treat …

Efficacy and safety of rituximab in the management of pediatric systemic lupus erythematosus: a systematic review

…, O Saidane, M Ferjani, Y Hammi, S Trabelsi… - The Journal of …, 2017 - Elsevier
Objectives To evaluate the efficacy and safety of rituximab for treating pediatric systemic
lupus erythematosus (pSLE). Study design We performed a systematic review to evaluate the …

Rituximab in the management of pediatric steroid-resistant nephrotic syndrome: a systematic review

…, R Charfi, B Maalej, A Mahfoud, S Trabelsi… - The Journal of …, 2018 - Elsevier
Objectives To evaluate the efficacy and safety of rituximab in children with steroid-resistant
nephrotic syndrome. Study design A systematic review evaluating the efficacy and safety of …

Digoxin therapeutic drug monitoring: age influence and adverse events.

…, E Gaies, N Jebabli, R Daghfous, S Trabelsi - La Tunisie …, 2020 - europepmc.org
INTRODUCTION: Digoxin is a cardiac glycoside, used to control rapid ventricular rates in
atrial fibrillation and to reduce the hospitalizations due to heart failure. Digoxin has a narrow …

Response to clopidogrel and of the cytochrome CYP2C19 gene polymorphism.

…, Y Gorgi, M Kharrat, H Baccar, S Trabelsi - La Tunisie …, 2018 - europepmc.org
Objective To evaluate the effect of Cyp2C19* 2 polymorphism on MACE occurrence and
hemorrhagic complications in patients treated with clopi. Methods We carried out a descriptive …

[HTML][HTML] Pharmacogenetic landscape of Metabolic Syndrome components drug response in Tunisia and comparison with worldwide populations

…, Y Hamdi, J Shan, A Abid, H Jamoussi, S Trabelsi… - PLoS …, 2018 - journals.plos.org
Genetic variation is an important determinant affecting either drug response or susceptibility
to adverse drug reactions. Several studies have highlighted the importance of ethnicity in …

Population pharmacokinetics and Bayesian estimation of cyclosporine in a Tunisian population of hematopoietic stem cell transplant recipient

…, NB Fradj, N Jebabli, I Salouage, S Trabelsi… - European journal of …, 2012 - Springer
Purpose Therapeutic drug monitoring of cyclosporine minimizes the risk of toxicity and
acute rejection after transplantation. Areas under the curve (AUCs) rather than trough …

Development and validation of a new HPLC method for determination of Lamotrigine and clinical application

…, R Charfi, M Lakhal, A Klouz, S Trabelsi… - La Tunisie …, 2015 - europepmc.org
Background Lamotrigine is an effective anticonvulsant drug used in the treatment of epilepsy.
It has a narrow therapeutic range, a large inter and intra-individual pharmacokinetic …

[HTML][HTML] Estimation of abbreviated cyclosporine A area under the concentration-time curve in allogenic stem cell transplantation after oral administration

…, N Ben Fradj, I Salouage, E Gaies, S Trabelsi… - Journal of …, 2012 - hindawi.com
Measurements of Cyclosporine (CsA) systemic exposure permit its dose adjustment in allogenic
stem cell transplantation recipients to prevent graft-versus-host disease. CsA LSSs were …

[HTML][HTML] Phylogenetic and amino acid signature analysis of the sars-cov-2s lineages circulating in Tunisia

…, I Kacem, NB Alya, A Benkahla, S Trabelsi… - Infection, Genetics and …, 2022 - Elsevier
Since the beginning of the Coronavirus disease-2019 pandemic, there has been a growing
interest in exploring SARS-CoV-2 genetic variation to understand the origin and spread of …